Esther Rodriguez-Villegas

Prof. Dr. Esther Rodriguez-Villegas

Wearable Technologies Lab and Circuits and Systems Group, Department of Electrical and Electronic Engineering, Imperial College London, London SW7 2AZ, UK

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RPRenard Xaviero Adhi Pramono
Renard Xaviero Adhi Pramono
SBStuart Bowyer
Stuart Bowyer
Esther Rodriguez-VillegasEsther Rodriguez-Villegas
Esther Rodriguez-Villegas
Automatic detection or classification of adventitious sounds is useful to assist physicians in diagnosing or monitoring diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and pneumonia. While computerised respiratory sound analysis, specifically for the detection or classification of adventitious sounds, has recently been the focus of an increasing number of studies, a standardised approach and comparison has not been well established. To provide a review of existing algorithms for the detection or classification of adventitious respiratory sounds. This systematic review provides a complete summary of methods used in the literature to give a baseline for future works. A systematic review of English articles published between 1938 and 2016, searched using the Scopus (1938-2016) and IEEExplore (1984-2016) databases. Additional articles were further obtained by references listed in the articles found. Search terms included adventitious sound detection, adventitious sound classification, abnormal respiratory sound detection, abnormal respiratory sound classification, wheeze detection, wheeze classification, crackle detection, crackle classification, rhonchi detection, rhonchi classification, stridor detection, stridor classification, pleural rub detection, pleural rub classification, squawk detection, and squawk classification. Only articles were included that focused on adventitious sound detection or classification, based on respiratory sounds, with performance reported and sufficient information provided to be approximately repeated. Investigators extracted data about the adventitious sound type analysed, approach and level of analysis, instrumentation or data source, location of sensor, amount of data obtained, data management, features, methods, and performance achieved. A total of 77 reports from the literature were included in this review. 55 (71.43%) of the studies focused on wheeze, 40 (51.95%) on crackle, 9 (11.69%) on stridor, 9 (11.69%) on rhonchi, and 18 (23.38%) on other sounds such as pleural rub, squawk, as well as the pathology. Instrumentation used to collect data included microphones, stethoscopes, and accelerometers. Several references obtained data from online repositories or book audio CD companions. Detection or classification methods used varied from empirically determined thresholds to more complex machine learning techniques. Performance reported in the surveyed works were converted to accuracy measures for data synthesis. Direct comparison of the performance of surveyed works cannot be performed as the input data used by each was different. A standard validation method has not been established, resulting in different works using different methods and performance measure definitions. A review of the literature was performed to summarise different analysis approaches, features, and methods used for the analysis. The performance of recent studies showed a high agreement with conventional non-automatic identification. This suggests that automated adventitious sound detection or classification is a promising solution to overcome the limitations of conventional auscultation and to assist in the monitoring of relevant diseases.

27 September 2011 in Medical & Biological Engineering & Computing
Verified
Journal Article
Closed access
PDF file
AAAmir M. Abdulghani
Amir M. Abdulghani
ACAlexander Casson
Alexander Casson
Esther Rodriguez-VillegasEsther Rodriguez-Villegas
Esther Rodriguez-Villegas

15 September 2022 in IEEE Access
Verified
Journal Article
Open access
MDMaha S. Diab
Maha S. Diab
Esther Rodriguez-VillegasEsther Rodriguez-Villegas
Esther Rodriguez-Villegas
The use of machine learning in medical and assistive applications is receiving significant attention thanks to the unique potential it offers to solve complex healthcare problems for which no other solutions had been found. Particularly promising in this field is the combination of machine learning with novel wearable devices. Machine learning models, however, suffer from being computationally demanding, which typically has resulted on the acquired data having to be transmitted to remote cloud servers for inference. This is not ideal from the system’s requirements point of view. Recently, efforts to replace the cloud servers with an alternative inference device closer to the sensing platform, has given rise to a new area of research Tiny Machine Learning (TinyML). In this work, we investigate the different challenges and specifications trade-offs associated to existing hardware options, as well as recently developed software tools, when trying to use microcontroller units (MCUs) as inference devices for health and care applications. The paper also reviews existing wearable systems incorporating MCUs for monitoring, and management, in the context of different health and care intended uses. Overall, this work addresses the gap in literature targeting the use of MCUs as edge inference devices for healthcare wearables. Thus, can be used as a kick-start for embedding machine learning models on MCUs, focusing on healthcare wearables.

12 August 2014 in Annals of Biomedical Engineering
Verified
Journal Article
Open access
PDF file
Syed Anas ImtiazSyed Anas Imtiaz
Syed Anas Imtiaz
Esther Rodriguez-VillegasEsther Rodriguez-Villegas
Esther Rodriguez-Villegas
The push towards low-power and wearable sleep systems requires using minimum number of recording channels to enhance battery life, keep processing load small and be more comfortable for the user. Since most sleep stages can be identified using EEG traces, enormous power savings could be achieved by using a single channel of EEG. However, detection of REM sleep from one channel EEG is challenging due to its electroencephalographic similarities with N1 and Wake stages. In this paper we investigate a novel feature in sleep EEG that demonstrates high discriminatory ability for detecting REM phases. We then use this feature, that is based on spectral edge frequency (SEF) in the 8–16 Hz frequency band, together with the absolute power and the relative power of the signal, to develop a simple REM detection algorithm. We evaluate the performance of this proposed algorithm with overnight single channel EEG recordings of 5 training and 15 independent test subjects. Our algorithm achieved sensitivity of 83%, specificity of 89% and selectivity of 61% on a test database consisting of 2221 REM epochs. It also achieved sensitivity and selectivity of 81 and 75% on PhysioNet Sleep-EDF database consisting of 8 subjects. These results demonstrate that SEF can be a useful feature for automatic detection of REM stages of sleep from a single channel EEG.

3 October 2014 in BMJ Open
Verified
Journal Article
Open access
PDF file
Esther Rodriguez-VillegasEsther Rodriguez-Villegas
Esther Rodriguez-Villegas
GCGwangwei Chen
Gwangwei Chen
JRJeremy Radcliffe
Jeremy Radcliffe
JDJohn Duncan
John Duncan
Rationale Current techniques for monitoring patients for apnoea suffer from significant limitations. These include insufficient availability to meet diagnostic needs, cost, accuracy of results in the presence of artefacts and difficulty of use in unsupervised conditions. Objectives We created and clinically tested a novel miniature medical device that targets overcoming these limitations. Methods We studied 20 healthy control participants and 10 patients who had been referred for sleep apnoea diagnosis. The performances of the new system and also of the Food and Drug Administration (FDA) approved SOMNO clinical system, conventionally used for sleep apnoea diagnosis were evaluated under the same conditions. Both systems were tested during a normal night of sleep in controls and patients. Their performances were quantified in terms of detection of apnoea and hypopnoea in individual 10 s epochs, which were compared with scoring of signals by a blinded clinician. Main results For spontaneous apnoeas during natural sleep and considering the clinician scorer as the gold standard, the new wearable apnoea detection device had 88.6% sensitivity and 99.6% specificity. In comparison the SOMNO system had 14.3% sensitivity and 99.3% specificity. The novel device had been specifically designed to detect apnoea, but if apnoea and hypopnoea during sleep were both considered in the assessment, the sensitivity and specificity were 77.1% and 99.7%, respectively, versus 54% and 98.5%, respectively, for the SOMNO. Conclusions The performance of the novel device compares very well to the scoring by an experienced clinician even in the presence of breathing artefacts, in this small pilot study. This can potentially make it a real solution for apnoea home monitoring.

21 December 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
NDNikesh Devani
Nikesh Devani
RPRenard Xaviero Adhi Pramono
Renard Xaviero Adhi Pramono
SISyed Anas Imtiaz
Syed Anas Imtiaz
SBStuart Bowyer
Stuart Bowyer
Esther Rodriguez-VillegasEsther Rodriguez-Villegas
Esther Rodriguez-Villegas
SMSwapna Mandal
Swapna Mandal
Objectives Obstructive sleep apnoea (OSA) is a heavily underdiagnosed condition, which can lead to significant multimorbidity. Underdiagnosis is often secondary to limitations in existing diagnostic methods. We conducted a diagnostic accuracy and usability study, to evaluate the efficacy of a novel, low-cost, small, wearable medical device, AcuPebble_SA100, for automated diagnosis of OSA in the home environment. Settings Patients were recruited to a standard OSA diagnostic pathway in an UK hospital. They were trained on the use of type-III-cardiorespiratory polygraphy, which they took to use at home. They were also given AcuPebble_SA100; but they were not trained on how to use it. Participants 182 consecutive patients had been referred for OSA diagnosis in which 150 successfully completed the study. Primary outcome measures Efficacy of AcuPebble_SA100 for automated diagnosis of moderate–severe-OSA against cardiorespiratory polygraphy (sensitivity/specificity/likelihood ratios/predictive values) and validation of usability by patients themselves in their home environment. Results After returning the systems, two expert clinicians, blinded to AcuPebble_SA100’s output, manually scored the cardiorespiratory polygraphy signals to reach a diagnosis. AcuPebble_SA100 generated automated diagnosis corresponding to four, typically followed, diagnostic criteria: Apnoea Hypopnoea Index (AHI) using 3% as criteria for oxygen desaturation; Oxygen Desaturation Index (ODI) for 3% and 4% desaturation criteria and AHI using 4% as desaturation criteria. In all cases, AcuPebble_SA100 matched the experts’ diagnosis with positive and negative likelihood ratios over 10 and below 0.1, respectively. Comparing against the current American Academy of Sleep Medicine’s AHI-based criteria demonstrated 95.33% accuracy (95% CI (90·62% to 98·10%)), 96.84% specificity (95% CI (91·05% to 99·34%)), 92.73% sensitivity (95% CI (82·41% to 97·98%)), 94.4% positive-predictive value (95% CI (84·78% to 98·11%)) and 95.83% negative-predictive value (95% CI (89·94% to 98·34%)). All patients used AcuPebble_SA100 correctly. Over 97% reported a strong preference for AcuPebble_SA100 over cardiorespiratory polygraphy. Conclusions These results validate the efficacy of AcuPebble_SA100 as an automated diagnosis alternative to cardiorespiratory polygraphy; also demonstrating that AcuPebble_SA100 can be used by patients without requiring human training/assistance. This opens the doors for more efficient patient pathways for OSA diagnosis. Trial registration number NCT03544086; ClinicalTrials.gov.